Insiders · GLSI

Eric Rothe

Director at Greenwich LifeSciences, Inc. (GLSI)

Eric Rothe has filed 2 insider reports with the SEC since June 2022, as director at Greenwich LifeSciences, Inc. (GLSI). The latest filing, on December 27, 2024, reports grant or award at Greenwich LifeSciences, Inc. (GLSI).

Filings
2
Companies
1
Bought on market
None
Sold on market
None

Companies where Eric Rothe is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Greenwich LifeSciences, Inc. logo
GLSI
Greenwich LifeSciences, Inc.
Director$19.25Dec 27, 2024

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Eric Rothe with

Other insiders at the same companies

Questions about Eric Rothe

What is Eric Rothe's role at Greenwich LifeSciences, Inc.?
Eric Rothe reports to the SEC as director at Greenwich LifeSciences, Inc. (GLSI), according to the latest filing on December 27, 2024.
Has Eric Rothe bought or sold stock recently?
No open-market purchases or sales by Eric Rothe are on file. The filings report grant or award.
How do I get alerts when Eric Rothe files?
Follow Eric Rothe on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Eric Rothe (SEC CIK 0001806919). Totals count each trade once, skipping amendments whose original is on file, from Jun 24, 2022 on. View on SEC EDGAR · Get this as JSON